FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1995890461> ?p ?o ?g. }

• W1995890461 endingPage "422" @default.
• W1995890461 startingPage "411" @default.
• W1995890461 abstract "Capecitabine is an oral anticancer prodrug which is converted to 5-fluorouracil (5-FU) via 3 enzymatic steps, these being 5’-deoxy-5-fluorocytidine (5’-DFCR), 5’-deoxy-5-fluorouridine (5’-DFUR), and finally 5-FU by carboxylesterase (CES), cytidine deaminase (CDA), and thymidine phosphorylase (TP), respectively. Because rats, mice and monkeys are used for preclinical safety studies, we investigated the in vitro conversion from capecitabine to 5-FU by hepatic and intestinal mucosal microsomes and cytosols, to compare their metabolic activity to that of humans. Capecitabine was hydrolyzed to 5’-DFCR in hepatic and intestinal mucosal microsomes in these animal species. In humans and monkeys, CLint (Vmax/Km) for the hydrolysis of capecitabine in intestine (expressed as µl/min/g tissue) was much lower than that in hepatic microsomes but, in rats and mice, CLint was higher in intestine than in liver. In humans and monkeys, similar Km values and inhibition patterns by tetrahydrouridine (THU) a CDA inhibitor, were observed in CDA activity of hepatic and intestinal cytosols. However, rats showed very low CDA activity and mice showed non-Michaelis-Menten kinetics and a different inhibition pattern by THU. Km values for TP activity were almost similar in rats, mice, monkeys and humans. In conclusion, it was confirmed that monkeys are a suitable animal model for the safety assessment of capecitabine in terms of metabolic enzymes and it was suggested that higher toxic incidences in mouse small intestine were related to high hydrolytic activity of capecitabine in the small intestine." @default.
• W1995890461 created "2016-06-24" @default.
• W1995890461 creator A5054571073 @default.
• W1995890461 creator A5055682556 @default.
• W1995890461 creator A5086387091 @default.
• W1995890461 creator A5086921634 @default.
• W1995890461 date "2011-01-01" @default.
• W1995890461 modified "2023-10-18" @default.
• W1995890461 title "Comparison of in vitro metabolic conversion of capecitabine to 5-FU in rats, mice, monkeys and humans - toxicological implications" @default.
• W1995890461 cites W1485550508 @default.
• W1995890461 cites W152943885 @default.
• W1995890461 cites W1986952772 @default.
• W1995890461 cites W1987465827 @default.
• W1995890461 cites W2026552058 @default.
• W1995890461 cites W2039639998 @default.
• W1995890461 cites W2044970916 @default.
• W1995890461 cites W2085705101 @default.
• W1995890461 cites W2087675944 @default.
• W1995890461 cites W2087977046 @default.
• W1995890461 cites W2090231975 @default.
• W1995890461 cites W2100925113 @default.
• W1995890461 cites W2125923056 @default.
• W1995890461 cites W2132545630 @default.
• W1995890461 cites W2133505009 @default.
• W1995890461 cites W2137194656 @default.
• W1995890461 cites W2140626944 @default.
• W1995890461 cites W2143333875 @default.
• W1995890461 cites W8337814 @default.
• W1995890461 doi "https://doi.org/10.2131/jts.36.411" @default.
• W1995890461 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21804305" @default.
• W1995890461 hasPublicationYear "2011" @default.
• W1995890461 type Work @default.
• W1995890461 sameAs 1995890461 @default.
• W1995890461 citedByCount "19" @default.
• W1995890461 countsByYear W19958904612013 @default.
• W1995890461 countsByYear W19958904612014 @default.
• W1995890461 countsByYear W19958904612018 @default.
• W1995890461 countsByYear W19958904612019 @default.
• W1995890461 countsByYear W19958904612020 @default.
• W1995890461 countsByYear W19958904612021 @default.
• W1995890461 countsByYear W19958904612023 @default.
• W1995890461 crossrefType "journal-article" @default.
• W1995890461 hasAuthorship W1995890461A5054571073 @default.
• W1995890461 hasAuthorship W1995890461A5055682556 @default.
• W1995890461 hasAuthorship W1995890461A5086387091 @default.
• W1995890461 hasAuthorship W1995890461A5086921634 @default.
• W1995890461 hasBestOaLocation W19958904611 @default.
• W1995890461 hasConcept C108215921 @default.
• W1995890461 hasConcept C121608353 @default.
• W1995890461 hasConcept C123321153 @default.
• W1995890461 hasConcept C126322002 @default.
• W1995890461 hasConcept C134018914 @default.
• W1995890461 hasConcept C150903083 @default.
• W1995890461 hasConcept C181199279 @default.
• W1995890461 hasConcept C185592680 @default.
• W1995890461 hasConcept C202751555 @default.
• W1995890461 hasConcept C207001950 @default.
• W1995890461 hasConcept C2776694085 @default.
• W1995890461 hasConcept C2776735402 @default.
• W1995890461 hasConcept C2777882243 @default.
• W1995890461 hasConcept C2777909004 @default.
• W1995890461 hasConcept C2778050828 @default.
• W1995890461 hasConcept C2780456651 @default.
• W1995890461 hasConcept C526805850 @default.
• W1995890461 hasConcept C55493867 @default.
• W1995890461 hasConcept C62231903 @default.
• W1995890461 hasConcept C71924100 @default.
• W1995890461 hasConcept C86803240 @default.
• W1995890461 hasConcept C87644729 @default.
• W1995890461 hasConcept C98274493 @default.
• W1995890461 hasConceptScore W1995890461C108215921 @default.
• W1995890461 hasConceptScore W1995890461C121608353 @default.
• W1995890461 hasConceptScore W1995890461C123321153 @default.
• W1995890461 hasConceptScore W1995890461C126322002 @default.
• W1995890461 hasConceptScore W1995890461C134018914 @default.
• W1995890461 hasConceptScore W1995890461C150903083 @default.
• W1995890461 hasConceptScore W1995890461C181199279 @default.
• W1995890461 hasConceptScore W1995890461C185592680 @default.
• W1995890461 hasConceptScore W1995890461C202751555 @default.
• W1995890461 hasConceptScore W1995890461C207001950 @default.
• W1995890461 hasConceptScore W1995890461C2776694085 @default.
• W1995890461 hasConceptScore W1995890461C2776735402 @default.
• W1995890461 hasConceptScore W1995890461C2777882243 @default.
• W1995890461 hasConceptScore W1995890461C2777909004 @default.
• W1995890461 hasConceptScore W1995890461C2778050828 @default.
• W1995890461 hasConceptScore W1995890461C2780456651 @default.
• W1995890461 hasConceptScore W1995890461C526805850 @default.
• W1995890461 hasConceptScore W1995890461C55493867 @default.
• W1995890461 hasConceptScore W1995890461C62231903 @default.
• W1995890461 hasConceptScore W1995890461C71924100 @default.
• W1995890461 hasConceptScore W1995890461C86803240 @default.
• W1995890461 hasConceptScore W1995890461C87644729 @default.
• W1995890461 hasConceptScore W1995890461C98274493 @default.
• W1995890461 hasIssue "4" @default.
• W1995890461 hasLocation W19958904611 @default.
• W1995890461 hasLocation W19958904612 @default.
• W1995890461 hasOpenAccess W1995890461 @default.
• W1995890461 hasPrimaryLocation W19958904611 @default.

• next